The recent development in CRISPR technology allows for personalized gene editing therapy, marking a significant advancement in the field. Previously, CRISPR therapies were limited to general gene edits for blood diseases like sickle cell disease and thalassemia, involving the removal and alteration of bone marrow cells. However, a new case report showcases the targeting of […]

In a groundbreaking achievement, prime editing technology successfully corrected a genetic mutation in hematopoietic stem cells, reversing the effects of CGD—a debilitating condition that compromises the immune system. This innovative approach offers new hope for patients facing severe infections and inflammatory diseases due to this mutation. Developed by a U.S.-based company, this advancement showcases the […]

In the field of gene therapy, prime editing emerges as a cutting-edge technology alongside Zinc-finger, Transcription Activator-like Effector, and CRISPR/Cas based gene editing. This advancement offers a comprehensive and high-quality gene editing service for the development of gene therapy treatments. With prime editing, researchers and clinicians can make precise changes to the genetic material, potentially […]